Caixia Li Selected Research

Acute Lung Injury

1/2023	Xuanfei Baidu Decoction suppresses complement overactivation and ameliorates IgG immune complex-induced acute lung injury by inhibiting JAK2/STAT3/SOCS3 and NF-κB signaling pathway.
4/2022	Syringaresinol Resisted Sepsis-Induced Acute Lung Injury by Suppressing Pyroptosis Via the Oestrogen Receptor-β Signalling Pathway.
1/2018	Resveratrol alleviates sepsis-induced acute lung injury by suppressing inflammation and apoptosis of alveolar macrophage cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Caixia Li Research Topics

Disease

31	Neoplasms (Cancer) 01/2024 - 03/2013
13	Inflammation (Inflammations) 04/2024 - 10/2014
10	Fibrosis (Cirrhosis) 08/2023 - 04/2011
7	Pain (Aches) 06/2022 - 01/2014
6	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 10/2014
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2023 - 12/2017
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2020
5	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2018
4	Thrombosis (Thrombus) 03/2024 - 01/2016
4	Parkinson Disease (Parkinson's Disease) 10/2023 - 01/2020
4	Body Weight (Weight, Body) 08/2023 - 05/2018
4	Lymphoma (Lymphomas) 01/2023 - 01/2022
4	Leukemia 01/2023 - 02/2014
4	Multiple Myeloma 01/2023 - 01/2021
4	Liver Neoplasms (Liver Cancer) 12/2022 - 02/2012
4	Sepsis (Septicemia) 04/2022 - 01/2018
4	Disease Progression 01/2022 - 06/2006
4	Infections 12/2021 - 05/2010
4	Hemorrhage 07/2021 - 06/2011
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 11/2017
4	Hypoxia (Hypoxemia) 01/2021 - 06/2008
4	IGA Glomerulonephritis (IGA Nephropathy) 08/2011 - 06/2006
3	Pneumonia (Pneumonitis) 01/2024 - 05/2010
3	Carcinogenesis 01/2024 - 01/2011
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2024 - 11/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 09/2023 - 07/2019
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 01/2020
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2019
3	Acute Lung Injury 01/2023 - 01/2018
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 11/2015
3	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2007
3	Thrombocytopenia (Thrombopenia) 12/2021 - 11/2018
3	Myocardial Infarction 07/2021 - 06/2020
2	Communicable Diseases (Infectious Diseases) 03/2024 - 05/2023
2	Atherosclerosis 03/2024 - 06/2020
2	Hyperlipidemias (Hyperlipidemia) 03/2024 - 01/2022
2	Adenocarcinoma 09/2023 - 01/2022
2	Neuralgia (Stump Neuralgia) 03/2023 - 04/2021
2	Demyelinating Diseases (Demyelinating Disease) 03/2023 - 07/2015
2	Hyperplasia 03/2023 - 01/2023
2	Ganglion Cysts (Ganglion) 01/2023 - 01/2021
2	Lung Injury 01/2023 - 10/2018
2	COVID-19 01/2023 - 10/2020
2	Type 2 Diabetes Mellitus (MODY) 02/2022 - 02/2021
2	Disease Resistance 01/2022 - 03/2018
2	Cytokine Release Syndrome 01/2022 - 01/2020
2	Stroke (Strokes) 07/2021 - 02/2021
2	Obesity 02/2021 - 12/2013
2	Diarrhea 02/2021 - 01/2018
2	Bullous Pemphigoid (Pemphigoid) 01/2021 - 01/2018
2	Blister (Bulla) 01/2021 - 01/2018
2	Philadelphia Chromosome 01/2020 - 02/2014

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 11/2023 - 08/2007
8	Chimeric Antigen ReceptorsIBA 09/2023 - 01/2020
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2013
4	CytokinesIBA 05/2018 - 01/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 03/2008
3	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2015
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 06/2020
3	RNA (Ribonucleic Acid)IBA 10/2020 - 01/2014
3	Protein Isoforms (Isoforms)IBA 08/2018 - 01/2015
2	NanovaccinesIBA 03/2024 - 05/2023
2	Amylases FDA Link 01/2024 - 01/2021
2	BilirubinIBA 01/2024 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 01/2023
2	plastrum testudinisIBA 10/2023 - 09/2021
2	VaccinesIBA 09/2023 - 04/2012
2	Silver Sulfadiazine (SSD)FDA LinkGeneric 09/2023 - 01/2021
2	InflammasomesIBA 08/2023 - 08/2020
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2020
2	zanubrutinibIBA 01/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2011
2	Retinaldehyde (Retinal)IBA 01/2023 - 01/2021
2	Imiquimod (Aldara)FDA LinkGeneric 01/2023 - 01/2019
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2022 - 01/2022
2	C-Reactive ProteinIBA 01/2022 - 01/2022
2	EnzymesIBA 01/2022 - 11/2016
2	InterleukinsIBA 01/2022 - 01/2019
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 01/2022 - 03/2018
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2019
2	HydrogelsIBA 01/2022 - 01/2020
2	Fingolimod Hydrochloride (FTY720)FDA Link 10/2021 - 01/2019
2	Therapeutic UsesIBA 06/2021 - 05/2018
2	N-glycolylneuraminyllactosylceramide (HD3)IBA 01/2021 - 09/2020
2	AutoantibodiesIBA 01/2021 - 01/2018
2	3,4-dihydroxyacetophenoneIBA 01/2021 - 09/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2010
2	CeramidesIBA 06/2020 - 11/2011

Therapy/Procedure

19	Therapeutics 11/2023 - 10/2014
8	Hematopoietic Stem Cell Transplantation 01/2023 - 10/2013
6	Drug Therapy (Chemotherapy) 11/2023 - 07/2019
4	Aftercare (After-Treatment) 06/2022 - 01/2018
2	Cell Transplantation 10/2023 - 11/2021
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2023 - 01/2019
2	Immunotherapy 01/2023 - 01/2022
2	Transplantation 01/2023 - 01/2023
2	Stem Cell Transplantation 12/2022 - 01/2019
2	Anesthesia 06/2021 - 10/2017
2	General Anesthesia 06/2021 - 10/2017